Hematology/Oncology News and Events
Drs. Davar and Zarour discuss their ongoing work on fecal microbiota transplants to improve response to immunotherapy
Dr. Hassane Zarour and Dr. Diwakar Davar are featured on UPMC Physician Journal discussing their ground breaking clinical trial published in Science and ongoing work on the benefits of fecal microbiota transplants to overcome anti-PD-1 therapy resistance and improve...
Groundbreaking new study by Dr. Warren Shlomchik et al provides new avenues for treatment in graft-versus-host disease
The paper, published in Immunity, showed that GVHD is maintained by donor T cells that seed those tissues soon after transplant and not by the continual recruitment of T cells from the blood as previously thought.
PACCM and Hematology/Oncology faculty collaborate to identify link between telomere mutations and melonama
In a recent Science paper, Drs. Jonathan Alder, John Kirkwood and others describe TPP1 mutations leading to telomere lengthening and the promotion of melanoma cells.
Division strongly represented at annual ASH meeting in New Orleans
Division of Hematology Oncology residents, trainees and faculty are strongly represented at this year's annual meeting of the American Society of Hematology (ASH) held in New Orleans, Louisiana, December 10-13, 2022, presenting their translational, clinical and basic...
Fall 2022 Research Highlights
Highlighted Publications A Phase 1 Dose Escalation Study of the Pyruvate Kinase Activator Mitapivat (AG-348) in Sickle Cell Disease. In this Phase 1 single-center, open-label study of the novel red-cell pyruvate kinase (PKR) activator mitapivat (AG-348) for the...
Dr. Taofeek Owonikoko Named Chief of the Division of Hematology/Oncology
Taofeek K. Owonikoko, MD, PhD, will join the Department of Medicine as chief of the Division of Hematology/Oncology. Owonikoko, a physician-scientist board-certified in medical oncology, hematology and internal medicine, will begin his appointment on July 1, 2021.
Welcome, New Faculty Dr. Jing Hong Wang!
UPMC Hillman Cancer Center is pleased to welcome Jing Hong Wang, M.D., Ph.D., to the faculty as a member of the cancer immunology and immunotherapy program. Wang will also be appointed as a professor of medicine in the Division of Hematology/Oncology at the University...
Hillman Announces New Director for Cell Therapy Laboratory
The UPMC Hillman Cancer Center today announced that Yen-Michael Hsu, M.D., Ph.D., will serve as the new as Director of the Immunologic Monitoring and Cellular Therapeutics Laboratory at (IMCPL).
UPMC Hillman Cancer Center Rated Exceptional by National Cancer Institute
Leading Research and Care Lead to Renewal as Region’s Only NCI-Designated Comprehensive Cancer CenterUPMC Hillman Cancer Center received an “exceptional” score, the highest achievable rating, and its largest grant to date when it was recently renewed as a National...
Jason Luke Receives Holzer Award
UPMC Hillman Cancer Center immunologist Jason Luke, MD, FACP, has been presented with the Sy Holzer Endowed Immunotherapy Research Fund Award to advance innovative research in cancer immunotherapy. Congratulations, Dr. Luke! Read more HERE and HERE.
Visit the UPMC Hillman Cancer Center events calendar for a listing of cancer related events and seminars.
Division of Hematology/Oncology
UPMC Cancer Pavilion
5150 Centre Avenue, 5th floor
Pittsburgh, PA 15232
412-648-6575 | Email Us
UPMC Hillman Cancer Center
5115 Centre Avenue
Pittsburgh, PA 15232